Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure

Multiple Myeloma Light Chain Induced Renal Insufficiency Clinical Trial

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to determine efficacy of lenalidomide and dexamethasone in the treatment of patients with acute Myeloma (light chain)-induced renal failure.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Multiple Myeloma
• Multiple Myeloma Light Chain Induced Renal Insufficiency
• Neoplasms, Plasma Cell
• Renal Insufficiency

• NCT number: NCT00902915
• Study type: Interventional
• Source: Austrian Forum Against Cancer
• Status: Active, not recruiting
• Phase: Phase 2
• Start date: May 2009
• Completion date: May 2014